Skip to main content
THC logo

THC · Tenet Healthcare Corp

Track THC — free
$267.75 -6.44 (-2.35%) At close · Aug 27
Market Cap
$22.08B
Shares
80.52M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$21.31B +3.1%
FY2025 Revenue FY2016–FY2025
Net Income
$2.37B -41.8%
FY2025 Net Income FY2008–FY2025
Operating Margin
16.46% -12.4pp
FY2025 Operating Margin FY2016–FY2025
Diluted EPS
$15.49 -52.6%
FY2025 Diluted EPS FY2008–FY2025
Operating Cash Flow
$3.54B +72.9%
FY2025 Operating Cash Flow FY2008–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008
$21.9B – $22.5B $21.81B $21.31B $20.68BG $20.56BG $19.17B $19.49B $17.64B $18.48B $18.31B $19.18B $19.62B
$166M $172M $174M $172M $188M $172M $188M $185M $172M $152M $144M
$893M $863M $818M $870M $841M $855M $857M $850M $802M $870M $850M $797M $849M $545M $430M $398M $380M $386M $371M
$6M $3M $16M -$14M -$13M -$1M $7M
$4.54B $3.51B $5.96B $2.51B $2.33B $2.87B $1.99B $1.54B $1.64B $1.11B $1.25B $1.08B $925M $663M $749M $653M $634M $538M $311M
16.46% 28.81% 12.21% 12.17% 14.73% 11.28% 8.32% 8.94% 5.8% 6.36%
$5.43B $4.37B $6.77B $3.38B $3.17B $3.73B $2.85B $2.39B $2.44B $1.98B $2.1B $1.87B $1.77B $1.21B $1.18B $1.05B $1.01B $924M $682M
$820M $821M $826M $901M $890M $923M $1B $985M $1B $1.03B $979M $912M $754M $474M $412M $375M $424M $445M $418M
$150M $117M $126M $19M $11M $14M $1M -$5M -$5M
$263M $264M $260M $228M $216M $218M $169M $175M $150M $144M $131M $99M $12M $15M $8M $8M $5M
$8M $1M $1M $1M $3M $5M $0 $22M
$3.17B $2.8B $5.25B $1.62B $1.35B $1.89B $671M $320M $629M -$101M $248M $144M $147M -$158M $334M $164M $158M $205M
$691M $433M $1.18B $306M $344M $411M -$97M $160M $173M $219M $67M $68M $49M -$65M $125M $61M -$977M -$23M -$25M
$3.17B $2.37B $4.06B $1.31B $1B $1.48B $768M $171M $459M -$320M $176M $78M $76M -$104M $133M $94M $1.12B $181M $25M
11.11% 19.66% 6.38% 5.22% 7.58% 4.35% 0.93% 2.51% -1.67% 0.9%
$933M $960M $864M $700M $590M $562M $369M $386M $355M $384M $368M $218M $64M $30M $12M $9M $10M $7M
$2.24B $1.41B $3.2B $611M $411M $914M $399M -$215M $104M -$704M -$192M -$140M $12M -$134M $141M $58M $1.12B $181M
$2.24B $1.41B $3.2B $611M $463M $962M $375M -$249M $128M -$650M -$286M -$122M -$146M -$90M $125M $49M $1.11B $186M $16M
USD/shares $26.12 $15.61 $33.02 $6.01 $3.84 $8.55 $3.80 -$2.08 $1.02 -$7.00 -$1.93 -$1.41 $0.12 -$1.32 $1.35 $0.49 $9.24 $0.38 $0.05
USD/shares $34.57 – $36.43 $25.93 $15.49G $32.70 $5.71G $3.79 $8.42 $3.75 -$2.08 $1.00 -$7.00 -$1.93 -$1.41 $0.12 -$1.32 $1.30 $0.48 $8.16 $0.37 $0.05
shares 90.15M 96.9M 101.64M 106.93M 106.83M 105.01M 103.4M 102.11M 100.59M 99.32M 99.17M 97.8M 101.65M 104.2M 117.18M 121.08M 480.24M 476.35M
shares 90.83M 97.88M 104.8M 110.52M 108.57M 106.26M 103.4M 103.88M 100.59M 99.32M 99.17M 100.29M 101.65M 108.93M 121.3M 140.16M 507.28M 478.61M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $3.45B in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
1.49×
Peer median 1.58×
EV/EBIT
7.15×
Peer median 19.30×
P/E (TTM)
10.57×
Peer median 19.10×

Peer medians compare against the 16 similar-size Medical Care Facilities companies (of 55 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Hospital Operations $16,138,000,000 $16,141,000,000 $16,698,000,000 $15,926,000,000 $16,767,000,000 $14,790,000,000 $15,522,000,000 $15,285,000,000
Ambulatory Care $5,172,000,000 $4,534,000,000 $3,866,000,000 $3,248,000,000 $2,718,000,000 $2,072,000,000 $2,158,000,000 $2,085,000,000
Conifer Segment $1,316,000,000 $1,267,000,000 $1,306,000,000 $1,372,000,000 $1,533,000,000
Core Services and Other Segment $2,158,000,000 $2,085,000,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Health Care Patient Service $4,956,000,000 $2,604,000,000 $1,960,000,000 $4,080,000,000 $3,930,000,000
Other Revenues $2,196,000,000 $2,008,000,000 $1,172,000,000 $1,154,000,000
Health Care Other Sources $216,000,000 $28,000,000 $26,000,000 $46,000,000 $56,000,000
Health Care Management Fees $86,000,000 $86,000,000 $190,000,000 $184,000,000
Insurance Recoveries $0 $34,000,000 $6,000,000
Key facts CIK 70318 CUSIP 88033G407 13F (30d) 513 filings 505 filers Visit website Investor relations